Načítá se...
No added diagnostic value of non-phosphorylated tau fraction (p-tau(rel)) in CSF as a biomarker for differential dementia diagnosis
BACKGROUND: The Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers Aβ(1–42), t-tau, and p-tau(181) overlap with other diseases. New tau modifications or epitopes, such as the non-phosphorylated tau fraction (p-tau(rel)), may improve differential dementia diagnosis. The goal of this study...
Uloženo v:
Vydáno v: | Alzheimers Res Ther |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
BioMed Central
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5513364/ https://ncbi.nlm.nih.gov/pubmed/28709448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0275-5 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|